Virus-Based therapy takes on tough cancers in new trial
Disease control
Recruiting now
This early-stage trial tests a new drug called OTS-412, made from a modified virus, alone or with hydroxyurea and atezolizumab in 27 adults with solid tumors that no longer respond to standard treatments. The main goal is to check safety and side effects, while also looking at wh…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated May 17, 2026 05:04 UTC